Poster presentations: Clinical - NMOSD & MOGAD workshop
Plasma exchange in attacks of MOGAD: a systematic review and meta-analysis
Roger Araujo
47
Optic Neuritis and Myelitis Following COVID-19 Vaccination: A Case Study
Juliana Avila Duarte
16
Tumefactive Demyelinating Lesions in a Young Patient: Rare Case with Good Outcome
Juliana Avila Duarte
18
Anti-MOG Optic Neuritis: Case Report and Insights into Diagnosis and Treatment
Juliana Avila Duarte
19
Brain lesion distribution distinguishing MS from other CNS inflammatory diseases
Igor Bessa Santiago
60
Challenges of Diagnosis for Seronegative Postrema Area Syndrome and Long Myelitis
Nathane Braga
41
Clinical Manifestations, Imaging, and Initial Treatment of MOGAD at national hospital Lima, Peru
Diego Canales
26
MOGAD Following Arbovirus Infection: A case report and Literature Review
Mariana de Oliveira Trintinalha
11
Seroreversion versus clinical scoring in predicting relapse in MOGAD
Guilherme Diogo Silva
55
Area postrema syndrome as first NMOSD attack, a single center retrospective study
Bruno Ferraz de Abreu
30
Failure to treatment with Rituximab in patients with AQP4+ NMOSD
Fernanda Flores Alfaro
75
Population study of NMOSD epidemiology over 12 years at Penang Island, Malaysia
Jyh Yung Hor
74
Afebrile appendicitis in a patient with AQP4+NMOSD under satralizumab treatment
Hiroshi Kuroda
53
Early clinical predictors of failure to oral immunosuppressive therapies in NMOSD
Ivna Lacerda Pereira Nobrega
45
Neutrophils in MOGAD/NMOSD: effectors of neural damage and differentiators vs MS
David Leppert
1
4-Octyl itaconate inhibits inflammation via the NLRP3 pathway in NMOSD
Young Investigator
Rui Liu
3
Characterizing Double-Negative NMOSD: A Systematic Review and Meta-Analysis
Young Investigator
Antonio Malvaso
2
Clinical disability in coexisting NMOSD and Systemic Autoimmune Diseases
Yazmin Martinez Lopez
50
Profile of Neuromyelitis Optica Patients Treated With Rituximab: An Initial Sample
Maria Eduarda Moreira Cardoso
59
Addressing Unmet Needs in NMOSD Care: Insights from a New Center in Brazil
Giordani Passos
65
Clinical and MRI Characteristics of Double-Seronegative NMO Phenotype in Brazil
Denison Pedrosa
63
AQP4-Related Optic Neuritis is the Leading Subtype of Atypical ON in Brazil
Marco Aurélio Lana Peixoto
34
AQP4-ON Drives the Greatest Burden Across Atypical Optic Neuritis Subtypes
Marco Aurélio Lana Peixoto
35
A Clinician’s Toolbox: Diagnosing Optic Neuritis with Limited Resources
Marco Aurélio Lana Peixoto
36
NMO-RG: A Friendly-User Data Platform for Real-World Research and Collaboration
Marco Aurélio Lana Peixoto
40
Contrasting Pre- and Post-Pubertal Pediatric NMOSD in the NMO-RG Cohort
Marco Aurélio Lana Peixoto
51
Anti-MOG Antibody Associated Disease neuro-ophthalmological features: case series
Carolina Pelayo
24
Clinical features of NMOSD and MOGAD: a single center study from South Brazil
Vitória Pimentel
71
Analysis of NMOSD in Brazil: A Study of 872 Patients from the NMO-RG Database
Thales Pinto
43
Defining Pediatric NMOSD in Brazil: A Cohort Analysis from the NMO-RG Database
Milena Pitombeira
52
Autoimmune comorbidities in individuals with neuromyelitis optica spectrum disorder
Rafael Queiroga
66
AQP4+ NMOSD: Characteristics and Prognostic Factors in a Diverse Chilean Cohort
César Romero
68
Characteristics of double seronegative optic neuritis in tertiary center in Brazil
Nathalia Rossoni Ronchi
7
Diagnostic Evaluation of Patients with Suspected atypical demyelinating diseases
Thiago Santillán
44
Challenges in Diagnosing MOGAD: A Case Initially Misidentified as Toxocariasis
Larissa Souza
73
A Clinician’s Toolbox: Diagnosing Optic Neuritis with Limited Resources
Natália C. Talim
14
Comparative neuro-ophthalmological evaluation of AQP4+ and AQP4- NMOSD patients.
Francisco Tavares
12
Treatment failure rates in NMOSD patients in an Argentinean registry
Veronica Tkachuk
64
Treatment response in NMOSD relapses: a retrospective study from Argentina
Veronica Tkachuk
69
Titers of MOG Antibody Detection: Fixed vs. Live Cells in Serum, a case report
José Miguel Valdés
31
Sensitivity-Specificity of Live vs Fixed CBA for MOG Ab: meta-analysis
José Miguel Valdés
62
The aetiology of AQP4 antibody production in Neuromyelitis optica spectrum disorder
Li-Jie Zhang
8
Epitope Characteristics of MOG Antibodies in MOG antibody-associated disease
Li-Jie Zhang
9